News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
670,162 Results
Type
Article (51440)
Company Profile (597)
Press Release (618123)
Multimedia
Podcasts (102)
Webinars (17)
Section
Business (185000)
Career Advice (2535)
Deals (33468)
Drug Delivery (123)
Drug Development (79486)
Employer Resources (156)
FDA (17377)
Job Trends (14761)
News (325944)
Policy (35020)
Tag
Academia (2706)
Academic (1)
Accelerated approval (14)
Adcomms (31)
Allergies (101)
Alliances (48860)
ALS (116)
Alzheimer's disease (1500)
Antibody-drug conjugate (ADC) (175)
Approvals (17359)
Artificial intelligence (373)
Autoimmune disease (35)
Automation (20)
Bankruptcy (325)
Best Places to Work (11618)
BIOSECURE Act (22)
Biosimilars (138)
Biotechnology (407)
Bladder cancer (95)
Brain cancer (40)
Breast cancer (378)
Cancer (2991)
Cardiovascular disease (240)
Career advice (2127)
Career pathing (31)
CAR-T (193)
CDC (39)
Cell therapy (520)
Cervical cancer (24)
Clinical research (65646)
Collaboration (1088)
Compensation (545)
Complete response letters (38)
COVID-19 (2796)
CRISPR (65)
C-suite (353)
Cystic fibrosis (116)
Data (3107)
Decentralized trials (2)
Denatured (26)
Depression (77)
Diabetes (368)
Diagnostics (6419)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (169)
Drug pricing (151)
Drug shortages (35)
Duchenne muscular dystrophy (157)
Earnings (74318)
Editorial (49)
Employer branding (18)
Employer resources (140)
Events (96212)
Executive appointments (820)
FDA (19251)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (10)
Funding (965)
Gene editing (140)
Generative AI (36)
Gene therapy (422)
GLP-1 (882)
Government (4882)
Grass and pollen (5)
Guidances (224)
Healthcare (18136)
HIV (41)
Huntington's disease (29)
IgA nephropathy (44)
Immunology and inflammation (167)
Immuno-oncology (13)
Indications (40)
Infectious disease (2991)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (73)
Intellectual property (130)
Interviews (459)
IPO (15515)
IRA (53)
Job creations (3615)
Job search strategy (1778)
Kidney cancer (11)
Labor market (51)
Layoffs (502)
Leadership (26)
Legal (8249)
Liver cancer (78)
Longevity (12)
Lung cancer (417)
Lymphoma (215)
Machine learning (12)
Management (55)
Manufacturing (455)
MASH (94)
Medical device (13347)
Medtech (13353)
Mergers & acquisitions (18699)
Metabolic disorders (923)
Multiple sclerosis (104)
NASH (20)
Neurodegenerative disease (142)
Neuropsychiatric disorders (42)
Neuroscience (2230)
NextGen: Class of 2025 (6628)
Non-profit (4402)
Now hiring (37)
Obesity (470)
Opinion (277)
Ovarian cancer (104)
Pain (127)
Pancreatic cancer (122)
Parkinson's disease (183)
Partnered (22)
Patents (336)
Patient recruitment (185)
Peanut (54)
People (52756)
Pharmaceutical (128)
Pharmacy benefit managers (25)
Phase I (20236)
Phase II (28499)
Phase III (21979)
Pipeline (1749)
Policy (239)
Postmarket research (2711)
Preclinical (8415)
Press Release (70)
Prostate cancer (152)
Psychedelics (39)
Radiopharmaceuticals (257)
Rare diseases (507)
Real estate (5661)
Recruiting (62)
Regulatory (24702)
Reports (41)
Research institute (2443)
Resumes & cover letters (417)
Rett syndrome (10)
RNA editing (10)
RSV (61)
Schizophrenia (98)
Series A (164)
Series B (113)
Service/supplier (25)
Sickle cell disease (65)
Special edition (22)
Spinal muscular atrophy (156)
Sponsored (36)
Startups (3541)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (70)
The Weekly (74)
Vaccines (885)
Venture capital (52)
Weight loss (315)
Women's health (41)
Worklife (17)
Date
Today (104)
Last 7 days (529)
Last 30 days (1871)
Last 365 days (30629)
2025 (18025)
2024 (34716)
2023 (38973)
2022 (49871)
2021 (54060)
2020 (52991)
2019 (45844)
2018 (35238)
2017 (33005)
2016 (31928)
2015 (36552)
2014 (28899)
2013 (24286)
2012 (26034)
2011 (26522)
2010 (24099)
Location
Africa (912)
Alabama (58)
Alaska (7)
Arizona (184)
Arkansas (13)
Asia (42202)
Australia (6989)
California (7311)
Canada (2311)
China (701)
Colorado (313)
Connecticut (325)
Delaware (198)
Europe (93013)
Florida (1137)
Georgia (259)
Hawaii (3)
Idaho (53)
Illinois (648)
India (31)
Indiana (353)
Iowa (19)
Japan (243)
Kansas (103)
Kentucky (32)
Louisiana (18)
Maine (56)
Maryland (1059)
Massachusetts (5497)
Michigan (220)
Minnesota (439)
Mississippi (3)
Missouri (104)
Montana (26)
Nebraska (24)
Nevada (74)
New Hampshire (71)
New Jersey (2148)
New Mexico (29)
New York (2063)
North Carolina (1083)
North Dakota (9)
Northern California (3135)
Ohio (227)
Oklahoma (13)
Oregon (41)
Pennsylvania (1546)
Puerto Rico (18)
Rhode Island (36)
South America (1226)
South Carolina (34)
South Dakota (1)
Southern California (2776)
Tennessee (119)
Texas (1112)
United States (27352)
Utah (206)
Virginia (208)
Washington D.C. (74)
Washington State (630)
West Virginia (3)
Wisconsin (82)
670,162 Results for "astellas pharma us".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mitsubishi Research Institute and Astellas Announce Collaboration to Support Pharma Startups in Japan
June 13, 2025
·
4 min read
Job Trends
Amidst Industry Challenges, 85% of Pharmas Increase Investment in AI
A new report found that 85% of pharma respondents are increasing their artificial intelligence investments, and 70% see AI as an immediate priority. Two experts discuss how biopharmas are implementing and adopting AI, including their increased use of external help with the process.
July 31, 2025
·
4 min read
·
Angela Gabriel
Earnings
GSK to Inject ‘Tens of Billions’ in US Amid Trump’s Tariffs, Pipeline Reshuffles
CEO Emma Walmsley maintained that continued investment in the U.S. is a priority for the pharma to ensure its medicines for the country are supplied domestically.
July 30, 2025
·
2 min read
·
Tristan Manalac
Tariffs
J&J CEO Duato Urges Tax Fix, Not Tariffs To Drive US Pharma Manufacturing
In the company’s first-quarter earnings call Tuesday, J&J CEO Joaquin Duato said there’s a better way to encourage drug manufacturing in the U.S. than President Donald Trump’s threatened pharma tariffs.
April 15, 2025
·
3 min read
·
Annalee Armstrong
Manufacturing
With Pharma Throwing Billions At US Manufacturing, Where Is The Cash Going?
Major pharmaceutical companies are committing billions to US manufacturing in an effort to avoid steep tariffs threatened by President Donald Trump.
April 29, 2025
·
2 min read
·
Annalee Armstrong
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
Playing both sides of trade war, pharma companies are asking for certain compensations for scientific innovation and a smoother regulatory framework.
April 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
LEO Pharma Announces FDA Approval of ANZUPGO® (delgocitinib) Cream in the U.S.
July 24, 2025
·
7 min read
Press Releases
Zenara Pharma Receives U.S. FDA Approval for First Generic of Sertraline Hydrochloride Capsules with 180-Day CGT Exclusivity
August 1, 2025
·
2 min read
BioMidwest
Astellas Names Michael Petroutsas as Head of US Commercial
Astellas Pharma Inc. Chief Commercial Officer Claus Zieler has named Michael Petroutsas as Head, United States Commercial, leading the Astellas Pharma US Inc. organization.
February 22, 2024
·
2 min read
1 of 67,017
Next
